Chemoinformaics analysis of 1,3-Bis(p-hydroxyphenyl)pentane-1,4-diene
| Molecular Weight | 252.313 | nRot | 4 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 14 |
| Exact Molecular Weight | 252.115 | nRing | 2 |
| Solubility: LogS | -3.061 | nHRing | 0 |
| Solubility: LogP | 3.569 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 40.6627 |
| nHD | 2 | BPOL | 16.0513 |
| QED | 0.805 |
| Synth | 2.92 |
| Natural Product Likeliness | 1.172 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.228 |
| Pgp-sub | 0.002 |
| HIA | 0.009 |
| CACO-2 | -4.701 |
| MDCK | 0.0000157 |
| BBB | 0.067 |
| PPB | 0.994814 |
| VDSS | 0.666 |
| FU | 0.00667312 |
| CYP1A2-inh | 0.926 |
| CYP1A2-sub | 0.561 |
| CYP2c19-inh | 0.87 |
| CYP2c19-sub | 0.107 |
| CYP2c9-inh | 0.708 |
| CYP2c9-sub | 0.966 |
| CYP2d6-inh | 0.879 |
| CYP2d6-sub | 0.901 |
| CYP3a4-inh | 0.762 |
| CYP3a4-sub | 0.353 |
| CL | 7.97 |
| T12 | 0.819 |
| hERG | 0.095 |
| Ames | 0.429 |
| ROA | 0.339 |
| SkinSen | 0.82 |
| Carcinogencity | 0.274 |
| EI | 0.155 |
| Respiratory | 0.83 |
| NR-Aromatase | 0.273 |
| Antiviral | No |
| Prediction | 0.758421 |